香港股市 已收市

DXCM Sep 2024 155.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
0.35000.0000 (0.00%)
市場開市。 截至 03:30PM EDT。
全螢幕
前收市價0.3500
開市0.3500
買盤0.0000
賣出價0.0000
拍板155.00
到期日2024-09-20
今日波幅0.3500 - 0.3500
合同範圍
成交量3
未平倉合約1.65k
  • Zacks

    DexCom's (DXCM) G6 CGM System Combines With AID in Netherlands

    DexCom (DXCM) announces expansion of its AID partnership in the Netherlands to offer an easier diabetes management experience.

  • Zacks

    Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

    Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.

  • InvestorPlace

    The 3 Best Diabetes Stocks to Buy in June 2024

    Since last October, there has been a marked reduction in fears about the sales of diabetes drugs dropping as a result weight-loss drugs. That’s because Dexcom (NASDAQ:DXCM) delivered stronger-than-expected third-quarter results in October. And during its Q3 earnings call, Dexcom actually reported that when diabetes patients are on the GLP-1 drugs, their demand for glucose monitors tend to rise. Dexcom and other diabetes stocks advanced significantly over the subsequent six months or so, but they